Strug­gling As­traZeneca ups the ante on mR­NA pipeline work

As­traZeneca is dou­bling down, again, on its ear­ly-stage mR­NA work.

The phar­ma gi­ant boost­ed its in­vest­ment in Mod­er­na last year, in­vest­ing an ad­di­tion­al …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA